| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Keros Therapeutics Inc (NASDAQ: KROS)
KROS Technical Analysis
4
| As on 9th Jun 2023 KROS STOCK Price closed @ 43.89 and we RECOMMEND Sell for LONG-TERM with Stoploss of 44.07 & Strong Sell for SHORT-TERM with Stoploss of 51.63 we also expect STOCK to react on Following IMPORTANT LEVELS. |
KROSSTOCK Price
| Open | 47.60 | Change | Price | % |
| High | 47.62 | 1 Day | -5.07 | -10.36 |
| Low | 42.23 | 1 Week | -5.26 | -10.70 |
| Close | 43.89 | 1 Month | 0.03 | 0.07 |
| Volume | 1133500 | 1 Year | -7.27 | -14.21 |
| 52 Week High 67.04 | 52 Week Low 26.03 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| KROS Daily Charts |
KROS Intraday Charts |
Whats New @ Bazaartrend |
KROS Free Analysis |
|
|
KROS Important Levels Intraday
| RESISTANCE | 54.28 |
| RESISTANCE | 50.95 |
| RESISTANCE | 48.89 |
| RESISTANCE | 46.83 |
| SUPPORT | 40.95 |
| SUPPORT | 38.89 |
| SUPPORT | 36.83 |
| SUPPORT | 33.50 |
KROS Forecast April 2024
| 4th UP Forecast | 83.72 |
| 3rd UP Forecast | 70.95 |
| 2nd UP Forecast | 63.05 |
| 1st UP Forecast | 55.16 |
| 1st DOWN Forecast | 32.62 |
| 2nd DOWN Forecast | 24.73 |
| 3rd DOWN Forecast | 16.83 |
| 4th DOWN Forecast | 4.06 |
KROS Weekly Forecast
| 4th UP Forecast | 57.32 |
| 3rd UP Forecast | 53.01 |
| 2nd UP Forecast | 50.35 |
| 1st UP Forecast | 47.69 |
| 1st DOWN Forecast | 40.09 |
| 2nd DOWN Forecast | 37.43 |
| 3rd DOWN Forecast | 34.77 |
| 4th DOWN Forecast | 30.46 |
KROS Forecast2024
| 4th UP Forecast | 128.5 |
| 3rd UP Forecast | 101.37 |
| 2nd UP Forecast | 84.59 |
| 1st UP Forecast | 67.82 |
| 1st DOWN Forecast | 19.96 |
| 2nd DOWN Forecast | 3.19 |
| 3rd DOWN Forecast | -13.59 |
| 4th DOWN Forecast | -40.72 |
Keros Therapeutics Inc ( NASDAQ USA Symbol : KROS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
KROS Business Profile
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis. It is also developing small molecule product candidate KER-047 that is being developed for the treatment of anemia, as well as for the treatment of fibrodysplasia ossificans progressiva, or FOP, and is currently in a Phase 1 clinical trial; and KER-012 being developed for the treatment of disorders associated with bone loss, such as osteoporosis and osteogenesis imperfecta, and for the treatment of pulmonary arterial hypertension, or PAH. The company was founded in 2015 and is headquartered in Lexington, Massachusetts. Address: 99 Hayden Avenue, Lexington, MA, United States, 02421
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service